4
Jun 2026
Bio‑Techne and Refeyn close critical gap in bispecific antibody and biosimilar characterization
Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated workflow for the characterization of charge and size variants in bispecific antibodies and biosimilars.